| The polycomb group protein EZH2 is involved in progression of prostate cancer S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ... Nature 419 (6907), 624-629, 2002 | 3320 | 2002 |
| Quality of life and satisfaction with outcome among prostate-cancer survivors MG Sanda, RL Dunn, J Michalski, HM Sandler, L Northouse, L Hembroff, ... New England Journal of Medicine 358 (12), 1250-1261, 2008 | 2654 | 2008 |
| Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer JT Wei, RL Dunn, MS Litwin, HM Sandler, MG Sanda Urology 56 (6), 899-905, 2000 | 1625 | 2000 |
| Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ... The Journal of urology 199 (3), 683-690, 2018 | 909 | 2018 |
| α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ... Jama 287 (13), 1662-1670, 2002 | 898 | 2002 |
| Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group MK Tuck, DW Chan, D Chia, AK Godwin, WE Grizzle, KE Krueger, W Rom, ... Journal of proteome research 8 (1), 113-117, 2009 | 834 | 2009 |
| Contemporary diagnosis and management of renal angiomyolipoma CP Nelson, MG Sanda The Journal of urology 168 (4 Part 1), 1315-1325, 2002 | 765 | 2002 |
| Autoantibody signatures in prostate cancer X Wang, J Yu, A Sreekumar, S Varambally, R Shen, D Giacherio, R Mehra, ... New England Journal of Medicine 353 (12), 1224-1235, 2005 | 759 | 2005 |
| An intra-tumoral niche maintains and differentiates stem-like CD8 T cells CS Jansen, N Prokhnevska, VA Master, MG Sanda, JW Carlisle, MA Bilen, ... Nature 576 (7787), 465-470, 2019 | 662 | 2019 |
| A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to … WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ... The Journal of urology 185 (5), 1650-1655, 2011 | 610 | 2011 |
| Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte … JW Simons, B Mikhak, JF Chang, AM DeMarzo, MA Carducci, M Lim, ... Cancer research 59 (20), 5160-5168, 1999 | 565 | 1999 |
| Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer JT Wei, RL Dunn, HM Sandler, PW McLaughlin, JE Montie, MS Litwin, ... Journal of Clinical Oncology 20 (2), 557-566, 2002 | 553 | 2002 |
| Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy DC Miller, MG Sanda, RL Dunn, JE Montie, H Pimentel, HM Sandler, ... Journal of Clinical Oncology 23 (12), 2772-2780, 2005 | 468 | 2005 |
| Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate … KM Szymanski, JT Wei, RL Dunn, MG Sanda Urology 76 (5), 1245-1250, 2010 | 449 | 2010 |
| Urine TMPRSS2: ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA SA Tomlins, SMJ Aubin, J Siddiqui, RJ Lonigro, L Sefton-Miller, S Miick, ... Science translational medicine 3 (94), 94ra72-94ra72, 2011 | 436 | 2011 |
| Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part II: recommended approaches and details of specific care options MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ... The Journal of urology 199 (4), 990-997, 2018 | 375 | 2018 |
| The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis A Pettersson, RE Graff, SR Bauer, MJ Pitt, RT Lis, EC Stack, NE Martin, ... Cancer epidemiology, biomarkers & prevention 21 (9), 1497-1509, 2012 | 367 | 2012 |
| Prospective assessment of patient reported urinary continence after radical prostatectomy JT Wei, RL Dunn, R Marcovich, JE Montie, MG Sanda The Journal of urology 164 (3 Part 1), 744-748, 2000 | 367 | 2000 |
| Prediction of erectile function following treatment for prostate cancer M Alemozaffar, MM Regan, MR Cooperberg, JT Wei, JM Michalski, ... Jama 306 (11), 1205-1214, 2011 | 356 | 2011 |
| Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer DR Rhodes, MG Sanda, AP Otte, AM Chinnaiyan, MA Rubin Journal of the National Cancer Institute 95 (9), 661-668, 2003 | 338 | 2003 |
